Osong public health and research perspectives · 2026
The clonality and dissemination of carbapenem-resistant Klebsiella pneumoniae in a tertiary hospital in Malaysia: a retrospective analysis from 2022 to 2023.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zainulabid Ummu Afeera, Neoh Hui-Min, Cheong Xiong Khee, Kori Najma, Lau Chee Lan, Sulaiman Sunita, Yusof Siti Rokiah, Faudzi Nur Ayuni Ahamad, Yahya Maliha Farah Nurhazirah, Gan Han Ming, Salleh Sharifah Azura, Periyasamy Petrick
Аннотация
BACKGROUND: Cases of nosocomial carbapenem-resistant Klebsiella pneumoniae (CRKP) have been increasing steadily since the 1990s. In this study, we sought to assess CRKP clonal diversity and patterns of dissemination at Hospital Canselor Tuanku Muhriz (HCTM), a tertiary university hospital located in Kuala Lumpur, Malaysia.
METHODS: From January 2022 to December 2023, all CRKP isolates from HCTM were included in the investigation. Associated patient demographic data and clinical histories were retrieved from hospital records. Antibiotic susceptibility data for the collected isolates were obtained from the HCTM diagnostic laboratory. Molecular typing was performed using enterobacterial repetitive intergenic consensus polymerase chain reaction (ERIC-PCR) to identify genetic clusters. Based on ERIC-PCR clustering results and epidemiological investigations, selected CRKP isolates were subjected to whole-genome sequencing (WGS) to validate clonal relatedness, identify antimicrobial resistance genes, and establish phylogenomic relationships.
RESULTS: During the study period, a total of 147 CRKP isolates were recovered from various wards across HCTM. All isolates exhibited resistance to imipenem, meropenem, or ertapenem, with 124 isolates confirmed as carbapenemase producers. ERIC-PCR identified 24 genetic clusters disseminated across 23 wards within HCTM. Twelve CRKP isolates were selected for WGS based on integrated epidemiological investigation and ERIC-PCR genotyping; sequence typing revealed ST17 as the dominant circulating CRKP lineage in the intensive care unit, ward 6E, and possibly across the hospital. The carbapenemase gene bla_NDM was detected in all WGS-analyzed CRKP isolates.
CONCLUSION: Integrating epidemiological investigation, phenotypic testing, molecular typing, and WGS is essential to understand resistance dynamics, map transmission, and guide hospital infection prevention strategies.
METHODS: From January 2022 to December 2023, all CRKP isolates from HCTM were included in the investigation. Associated patient demographic data and clinical histories were retrieved from hospital records. Antibiotic susceptibility data for the collected isolates were obtained from the HCTM diagnostic laboratory. Molecular typing was performed using enterobacterial repetitive intergenic consensus polymerase chain reaction (ERIC-PCR) to identify genetic clusters. Based on ERIC-PCR clustering results and epidemiological investigations, selected CRKP isolates were subjected to whole-genome sequencing (WGS) to validate clonal relatedness, identify antimicrobial resistance genes, and establish phylogenomic relationships.
RESULTS: During the study period, a total of 147 CRKP isolates were recovered from various wards across HCTM. All isolates exhibited resistance to imipenem, meropenem, or ertapenem, with 124 isolates confirmed as carbapenemase producers. ERIC-PCR identified 24 genetic clusters disseminated across 23 wards within HCTM. Twelve CRKP isolates were selected for WGS based on integrated epidemiological investigation and ERIC-PCR genotyping; sequence typing revealed ST17 as the dominant circulating CRKP lineage in the intensive care unit, ward 6E, and possibly across the hospital. The carbapenemase gene bla_NDM was detected in all WGS-analyzed CRKP isolates.
CONCLUSION: Integrating epidemiological investigation, phenotypic testing, molecular typing, and WGS is essential to understand resistance dynamics, map transmission, and guide hospital infection prevention strategies.